Tilray Inc (NASDAQ:TLRY – Get Free Report) traded down 1.5% on Wednesday . The company traded as low as $1.62 and last traded at $1.63. 8,519,988 shares traded hands during trading, a decline of 66% from the average session volume of 25,141,068 shares. The stock had previously closed at $1.65.
Tilray Trading Down 0.9 %
The company has a market capitalization of $1.27 billion, a PE ratio of -3.72 and a beta of 2.13. The company has a current ratio of 2.27, a quick ratio of 1.42 and a debt-to-equity ratio of 0.10. The stock has a fifty day moving average of $1.77 and a two-hundred day moving average of $1.87.
Tilray (NASDAQ:TLRY – Get Free Report) last announced its quarterly earnings data on Monday, July 29th. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). The firm had revenue of $229.90 million for the quarter, compared to analysts’ expectations of $226.20 million. Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The business’s quarterly revenue was up 24.8% on a year-over-year basis. During the same period in the prior year, the business posted ($0.15) earnings per share. As a group, sell-side analysts anticipate that Tilray Inc will post -0.16 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Tilray
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
See Also
- Five stocks we like better than Tilray
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 3 Momentum Trades for October With Ample Upside Ahead
- The Role Economic Reports Play in a Successful Investment Strategy
- Roblox Dips on Short Report—Here’s Why It Could Bounce Back Fast
- How to Use Stock Screeners to Find Stocks
- 2 Reasons to Jump on Apple Stock Now and 1 Reason to Think Twice
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.